U.S. Department of Health & Human Services
Government organization
Active
Washington, United States
81
15M
76
2.31
36
0.06
8
- Areas of investment
Summary
In 1989 was created U.S. Department of Health & Human Services, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Washington.
Considering the real fund results, this Corporate Investor is 36 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this U.S. Department of Health & Human Services performs on 16 percentage points less the average number of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund. The top activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the U.S. Department of Health & Human Services, startups are often financed by Walton Family Foundation, National Science Foundation, American Heart Association. The meaningful sponsors for the fund in investment in the same round are National Institutes of Health. In the next rounds fund is usually obtained by gener8tor, Village Capital, Right Side Capital Management.
Among the most popular portfolio startups of the fund, we may highlight TCARE, Fletcher Group, Mapp Biopharmaceutical. Among the most popular fund investment industries, there are Food and Beverage, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 16-20 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 81
- Lead investments
- 36
- Exits
- 8
- Rounds per year
- 2.31
- Follow on index
- 0.06
- Investments by industry
- Health Care (41)
- Medical (17)
- Non Profit (17)
- Biotechnology (14)
- Education (11) Show 67 more
- Investments by region
-
- United States (76)
- South Korea (1)
- Luxembourg (1)
- The Netherlands (1)
- United Kingdom (1)
- Peak activity year
- 2023
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 48
- Avg. valuation at time of investment
- 52M
- Group Appearance index
- 0.26
- Avg. company exit year
- 20
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Mission Bio | 27 Jun 2018 | Biotechnology, Health Care, Genetics, Bioinformatics | Early Stage Venture | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.